To Combine or Not to Combine: Do We Need Concomitant Immunomodulators When Using Non-TNF-Targeting Biologics?

Clin Gastroenterol Hepatol. 2023 Oct;21(11):2743-2745. doi: 10.1016/j.cgh.2023.01.041. Epub 2023 Feb 18.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Biological Products* / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Tumor Necrosis Factor-alpha

Substances

  • Biological Products
  • Immunologic Factors
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha